✦ LIBER ✦

Cancer Chemotherapy: A Paclitaxel Prodrug for ADEPT (Antibody-Directed Enzyme Prodrug Therapy)

✍ Scribed by Frédéric Schmidt; Ioana Ungureanu; Romain Duval; Alain Pompon; Claude Monneret

Publisher: John Wiley and Sons
Year: 2001
Tongue: English
Weight: 353 KB
Volume: 2001
Category: Article
ISSN: 1434-193X
DOI: 10.1002/1099-0690(200106)2001:11<2129::aid-ejoc2129>3.0.co;2-#

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Proof of Principle in the Selective Trea

Proof of Principle in the Selective Treatment of Cancer by Antibody-Directed Enzyme Prodrug Therapy: The Development of a Highly Potent Prodrug

✍ Lutz F. Tietze; Tim Feuerstein; Anja Fecher; Frank Haunert; Olaf Panknin; Ulrich 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB 👁 1 views

Proof of Principle in the Selective Trea

Proof of Principle in the Selective Treatment of Cancer by Antibody-Directed Enzyme Prodrug Therapy: The Development of a Highly Potent Prodrug

✍ Lutz F. Tietze; Tim Feuerstein; Anja Fecher; Frank Haunert; Olaf Panknin; Ulrich 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB 👁 1 views

Highly Selective Glycosylated Prodrugs o

Highly Selective Glycosylated Prodrugs of Cytostatic CC-1065 Analogues for Antibody-Directed Enzyme Tumor Therapy

✍ Lutz F. Tietze; Tobias Herzig; Anja Fecher; Frank Haunert; Ingrid Schuberth 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB

Novel prodrugs of the cytotoxic antibiotic CC-1065 for an antibody-directed enzyme prodrug therapy (ADEPT) were prepared that show an excellent selectivity with a high toxicity of the corresponding drug. In particular, the seco-CBI analogue of CC-1065, 1-chloromethyl-5-hydroxy-1,2-dihydro-3H-benz[e]